PCSK928:

Yuanlu Shu1, Ziwei Deng2, Ye Deng2

  • 1Evidence-based Medicine and Clinical Center, The First People's Hospital of Huaihua, Huaihua, 418000, P.R. China.

BMC emergency medicine
|October 31, 2023
PubMed
概括

增加的前蛋白转化酶亚素/素9 (PCSK9) 水平与败血症患者28天死亡率的增加有关. 循环中的PCSK9可以作为败血症结果的预后生物标志物.